Feed/Investors/AyurMaya Capital Management

AyurMaya Capital Management

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-11-17

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$120M

across 1 round

LATEST ROUND

Funding round · $120M · 2025-11-17

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Solve Therapeutics Novel antibody-drug conjugates (ADCs) for cancer treatment targeted at solid tumors and optimized for payload delivery using proprietary technology.	Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$120M	2025-11-17	[ PART ]